
### [MONDO:0019050](http://purl.obolibrary.org/obo/MONDO_0019050)
**Label:** hemoglobinopathy

**Subclasses:** [MONDO:0019537](http://purl.obolibrary.org/obo/MONDO_0019537) (hemoglobin d disease), [MONDO:0010480](http://purl.obolibrary.org/obo/MONDO_0010480) (anemia, nonspherocytic hemolytic, due to G6Pd deficiency), [MONDO:0016489](http://purl.obolibrary.org/obo/MONDO_0016489) (delta-beta-thalassemia), [MONDO:0016488](http://purl.obolibrary.org/obo/MONDO_0016488) (beta-thalassemia associated with another hemoglobin anomaly), [MONDO:0016667](http://purl.obolibrary.org/obo/MONDO_0016667) (sickle cell disease associated with an other hemoglobin anomaly), [MONDO:0018963](http://purl.obolibrary.org/obo/MONDO_0018963) (hereditary methemoglobinemia), [MONDO:0017238](http://purl.obolibrary.org/obo/MONDO_0017238) (hemoglobinopathy Toms river), [MONDO:0016243](http://purl.obolibrary.org/obo/MONDO_0016243) (hemoglobin E disease), [MONDO:0016242](http://purl.obolibrary.org/obo/MONDO_0016242) (hemoglobin c disease), [MONDO:0016487](http://purl.obolibrary.org/obo/MONDO_0016487) (beta-thalassemia intermedia), [MONDO:0018740](http://purl.obolibrary.org/obo/MONDO_0018740) (acquired methemoglobinemia), [MONDO:0013275](http://purl.obolibrary.org/obo/MONDO_0013275) (hemolytic anemia due to glucophosphate isomerase deficiency), [MONDO:0016486](http://purl.obolibrary.org/obo/MONDO_0016486) (beta-thalassemia major), [MONDO:0009950](http://purl.obolibrary.org/obo/MONDO_0009950) (pyruvate kinase deficiency of red cells), [MONDO:0018022](http://purl.obolibrary.org/obo/MONDO_0018022) (hemoglobin Lepore-beta-thalassemia syndrome), [MONDO:0018023](http://purl.obolibrary.org/obo/MONDO_0018023) (hemoglobin M disease), [MONDO:0008545](http://purl.obolibrary.org/obo/MONDO_0008545) (thalassemia, beta+, silent Allele), [MONDO:0008789](http://purl.obolibrary.org/obo/MONDO_0008789) (anemia, nonspherocytic hemolytic, associated with abnormality of red cell membrane), [MONDO:0013517](http://purl.obolibrary.org/obo/MONDO_0013517) (beta-thalassemia), [MONDO:0011399](http://purl.obolibrary.org/obo/MONDO_0011399) (alpha thalassemia), [MONDO:0018749](http://purl.obolibrary.org/obo/MONDO_0018749) (hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome), [MONDO:0016669](http://purl.obolibrary.org/obo/MONDO_0016669) (sickle cell-hemoglobin c disease syndrome), [MONDO:0010745](http://purl.obolibrary.org/obo/MONDO_0010745) (beta-thalassemia-X-linked thrombocytopenia syndrome), [MONDO:0015579](http://purl.obolibrary.org/obo/MONDO_0015579) (Hb Bart's hydrops fetalis), [MONDO:0013512](http://purl.obolibrary.org/obo/MONDO_0013512) (hemoglobin H disease), [MONDO:0016668](http://purl.obolibrary.org/obo/MONDO_0016668) (sickle cell-beta-thalassemia disease syndrome), [MONDO:0010328](http://purl.obolibrary.org/obo/MONDO_0010328) (alpha-thalassemia-myelodysplastic syndrome), [MONDO:0011382](http://purl.obolibrary.org/obo/MONDO_0011382) (sickle cell anemia), [MONDO:0016513](http://purl.obolibrary.org/obo/MONDO_0016513) (alpha-thalassemia-related diseases), [MONDO:0011381](http://purl.obolibrary.org/obo/MONDO_0011381) (dominant beta-thalassemia), [MONDO:0008790](http://purl.obolibrary.org/obo/MONDO_0008790) (anemia, nonspherocytic hemolytic, possibly due to defect 1N porphyrin metabolism), [MONDO:0016672](http://purl.obolibrary.org/obo/MONDO_0016672) (hereditary persistence of fetal hemoglobin-sickle cell disease syndrome), [MONDO:0017145](http://purl.obolibrary.org/obo/MONDO_0017145) (beta-thalassemia and related diseases), [MONDO:0019402](http://purl.obolibrary.org/obo/MONDO_0019402) (beta thalassemia), [MONDO:0016671](http://purl.obolibrary.org/obo/MONDO_0016671) (sickle cell-hemoglobin E disease syndrome), [MONDO:0017144](http://purl.obolibrary.org/obo/MONDO_0017144) (alpha-thalassemia and related diseases), [MONDO:0018750](http://purl.obolibrary.org/obo/MONDO_0018750) (class i glucose-6-phosphate dehydrogenase deficiency), [MONDO:0017146](http://purl.obolibrary.org/obo/MONDO_0017146) (sickle cell disease and related diseases), [MONDO:0016492](http://purl.obolibrary.org/obo/MONDO_0016492) (beta-thalassemia with other manifestations), [MONDO:0016491](http://purl.obolibrary.org/obo/MONDO_0016491) (hemoglobin E-beta-thalassemia syndrome), [MONDO:0016670](http://purl.obolibrary.org/obo/MONDO_0016670) (sickle cell-hemoglobin d disease syndrome), [MONDO:0007716](http://purl.obolibrary.org/obo/MONDO_0007716) (alpha thalassemia-intellectual disability syndrome type 1), [MONDO:0009604](http://purl.obolibrary.org/obo/MONDO_0009604) (methemoglobin reductase deficiency), [MONDO:0016490](http://purl.obolibrary.org/obo/MONDO_0016490) (hemoglobin c-beta-thalassemia syndrome), [MONDO:0009605](http://purl.obolibrary.org/obo/MONDO_0009605) (methemoglobinemia type 4), [MONDO:0020459](http://purl.obolibrary.org/obo/MONDO_0020459) (Unstable hemoglobin disease), [MONDO:0009606](http://purl.obolibrary.org/obo/MONDO_0009606) (methemoglobinemia due to deficiency of methemoglobin reductase), [MONDO:0010519](http://purl.obolibrary.org/obo/MONDO_0010519) (alpha thalassemia-X-linked intellectual disability syndrome), 

**Corr. equiv. classes:** [Orphanet:231222](http://www.orpha.net/ORDO/Orphanet_231222), [Orphanet:231386](http://www.orpha.net/ORDO/Orphanet_231386), [Orphanet:231226](http://www.orpha.net/ORDO/Orphanet_231226), [OMIM:266200](http://purl.obolibrary.org/obo/OMIM_266200), [OMIM:300448](http://purl.obolibrary.org/obo/OMIM_300448), [OMIM:314050](http://purl.obolibrary.org/obo/OMIM_314050), [Orphanet:251359](http://www.orpha.net/ORDO/Orphanet_251359), [OMIM:206300](http://purl.obolibrary.org/obo/OMIM_206300), [OMIM:613985](http://purl.obolibrary.org/obo/OMIM_613985), [Orphanet:251355](http://www.orpha.net/ORDO/Orphanet_251355), [Orphanet:712](http://www.orpha.net/ORDO/Orphanet_712), [Orphanet:466026](http://www.orpha.net/ORDO/Orphanet_466026), [Orphanet:232](http://www.orpha.net/ORDO/Orphanet_232), [Orphanet:231230](http://www.orpha.net/ORDO/Orphanet_231230), [Orphanet:232288](http://www.orpha.net/ORDO/Orphanet_232288), [Orphanet:231393](http://www.orpha.net/ORDO/Orphanet_231393), [OMIM:250800](http://purl.obolibrary.org/obo/OMIM_250800), [Orphanet:231237](http://www.orpha.net/ORDO/Orphanet_231237), [Orphanet:46532](http://www.orpha.net/ORDO/Orphanet_46532), [OMIM:613470](http://purl.obolibrary.org/obo/OMIM_613470), [Orphanet:2133](http://www.orpha.net/ORDO/Orphanet_2133), [Orphanet:2132](http://www.orpha.net/ORDO/Orphanet_2132), [OMIM:604131](http://purl.obolibrary.org/obo/OMIM_604131), [Orphanet:330032](http://www.orpha.net/ORDO/Orphanet_330032), [Orphanet:621](http://www.orpha.net/ORDO/Orphanet_621), [Orphanet:251380](http://www.orpha.net/ORDO/Orphanet_251380), [Orphanet:99139](http://www.orpha.net/ORDO/Orphanet_99139), [OMIM:187550](http://purl.obolibrary.org/obo/OMIM_187550), [Orphanet:231242](http://www.orpha.net/ORDO/Orphanet_231242), [Orphanet:231249](http://www.orpha.net/ORDO/Orphanet_231249), [Orphanet:231401](http://www.orpha.net/ORDO/Orphanet_231401), [Orphanet:275745](http://www.orpha.net/ORDO/Orphanet_275745), [Orphanet:163596](http://www.orpha.net/ORDO/Orphanet_163596), [Orphanet:90039](http://www.orpha.net/ORDO/Orphanet_90039), [OMIM:206400](http://purl.obolibrary.org/obo/OMIM_206400), [Orphanet:251375](http://www.orpha.net/ORDO/Orphanet_251375), [Orphanet:330041](http://www.orpha.net/ORDO/Orphanet_330041), [Orphanet:251370](http://www.orpha.net/ORDO/Orphanet_251370), [Orphanet:98791](http://www.orpha.net/ORDO/Orphanet_98791), [OMIM:301040](http://purl.obolibrary.org/obo/OMIM_301040), [OMIM:250700](http://purl.obolibrary.org/obo/OMIM_250700), [OMIM:603903](http://purl.obolibrary.org/obo/OMIM_603903), [OMIM:603902](http://purl.obolibrary.org/obo/OMIM_603902), [Orphanet:231214](http://www.orpha.net/ORDO/Orphanet_231214), [Orphanet:275749](http://www.orpha.net/ORDO/Orphanet_275749), [OMIM:300908](http://purl.obolibrary.org/obo/OMIM_300908), [Orphanet:848](http://www.orpha.net/ORDO/Orphanet_848), [Orphanet:275752](http://www.orpha.net/ORDO/Orphanet_275752), [Orphanet:93616](http://www.orpha.net/ORDO/Orphanet_93616), [Orphanet:251365](http://www.orpha.net/ORDO/Orphanet_251365), [Orphanet:847](http://www.orpha.net/ORDO/Orphanet_847), [OMIM:613978](http://purl.obolibrary.org/obo/OMIM_613978), [Orphanet:846](http://www.orpha.net/ORDO/Orphanet_846), [OMIM:250790](http://purl.obolibrary.org/obo/OMIM_250790), [Orphanet:280615](http://www.orpha.net/ORDO/Orphanet_280615), [Orphanet:464453](http://www.orpha.net/ORDO/Orphanet_464453), [Orphanet:766](http://www.orpha.net/ORDO/Orphanet_766), [OMIM:141750](http://purl.obolibrary.org/obo/OMIM_141750), 

**Class expressions from DL-Learner:**

- [HP:0011902](http://purl.obolibrary.org/obo/HP_0011902) (Abnormal hemoglobin) 63.99%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0011902](http://purl.obolibrary.org/obo/HP_0011902) (Abnormal hemoglobin) 63.93%
- [HP:0010972](http://purl.obolibrary.org/obo/HP_0010972) (Anemia of inadequate production) and [HP:0011902](http://purl.obolibrary.org/obo/HP_0011902) (Abnormal hemoglobin) 62.93%
- [HP:0001935](http://purl.obolibrary.org/obo/HP_0001935) (Microcytic anemia) and [HP:0011902](http://purl.obolibrary.org/obo/HP_0011902) (Abnormal hemoglobin) 62.93%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0011902](http://purl.obolibrary.org/obo/HP_0011902) (Abnormal hemoglobin) 61.34%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0011902](http://purl.obolibrary.org/obo/HP_0011902) (Abnormal hemoglobin) 61.34%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0011902](http://purl.obolibrary.org/obo/HP_0011902) (Abnormal hemoglobin) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 58.57%
- [HP:0011902](http://purl.obolibrary.org/obo/HP_0011902) (Abnormal hemoglobin) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 56.23%
- [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) 39.75%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) 36.14%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 34.99%
- Thing 31.36%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 31.36%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 30.47%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 23.35%


